07:00 , Jul 15, 2013 |  BC Week In Review  |  Company News

Ahn-Gook, Gravity Bio Inc. deal

Gravity Bio said it received exclusive rights from Ahn-Gook to develop and commercialize cough and congestion drug Synatura in the U.S., Europe and undisclosed countries. The companies have also agreed to collaborate worldwide on further...
07:00 , Jun 17, 2013 |  BC Week In Review  |  Company News

Ahn-Gook, EffRx sales and marketing update

EffRx granted Ahn-Gook exclusive rights to develop and commercialize osteoporosis product Binosto alendronate in South Korea. Ahn-Gook anticipates approval of the alendronate effervescent and its subsequent launch in South Korea next year. FDA approved...